Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells

Journal of Leukocyte Biology

Volumn 60, Issue 3, 1996, Pages 405-414

  Bian, Zong Mei ^a   Elner, Susan G ^a   Strieter, Robert M ^a   Glass, Mary B ^a   Lukacs, Nicholas W ^a   Kunkel, Steven L ^a   Elner, Victor M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Interleukin 8; Monocyte chemotactic protein 1

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; GLUCOSE; GLYCOSYLATED ALBUMIN; INSULIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL;

EID: 0029834157     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.3.405     Document Type: Article

References (62)

1. Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., DeMets, D. L. (1988) Glycosylated haemoglobin predicts the incidence and progression of diabetic retinopathy. J. Am. Med. Assoc. 260, 2864-2871.
2. Winterhalter, K. H. (1985) Non-enzymatic glycosylation of proteins. Prog. Clin. Biol. Res. 195, 109-120.
3. Kennedy, L. Baynes, J. W. (1984) Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 26, 93-98.
4. Brownlee, M., Vlassara, H., Cerami, A. (1984) Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Int. Med. 101, 527-537.
5. Brownlee, M., Cerami, A., Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321.
6. Bron, A. J., Sparrow, J., Brown, N. A. P., Harding, J. J., Blakytny, R. (1993) The lens in diabetes. Eye 7, 260-275.
7. Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P., Kohn, R. R. (1984) Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314, 403-408.
8. Brinchmann-Hansen, O., Dahl-Jorgensen, K., Sandvik, L., Hanssen, K. F. (1992) Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. Br. Med. J. 304, 19-22.
9. Elner, V. M., Strieter, R. M., Elner, S. G., Baggiolini, M., Lindley, I., Kunkel, S. L. (1990) Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol. 136, 745-750.
10. Elner, S. G., Stricter, R. M., Elner, V. M., Rollins, B. J., Del Monte, M. A., Kunkel, S. L. (1991) Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab. Invest. 64, 819-825.
11. Sebag, J., Buckingham, B., Charles, M. A., Reiser, K. (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch. Ophthalmol. 110, 1472-1476.
12. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., Leonard, E. J. (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad.Sci USA 84, 9233-9237.
13. Erger, R. A., Casale, T. B. (1995) Inlerleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium Am. J. Physiol. 268, L117-L122.
14. Elner, S. G., Elner, V. M., Jaffe, G. J., Strieter, R. M. (1995) Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr. Eye. Res. 14, 1045-1053.
15. Taub, D. D., Proost, P., Murphy, W. J., Anver, M., Longo, D. L., Van Damme, J., Oppenheim, J. J. (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95, 1370-1376.
16. Rollins, B. J, Walz, A., Baggiolini, M. (1991) Recombinant human MCP-1/JE induces chemotaxis, calcium flux,and the respiratory burst in human monocytes, Blood 78, 1112-1116.
17. Koch, A. E., Kunkel, S. L., Shah, M. R., Hosaka, S., Halloran, M. M., Haines, G. K., Burdick, M. D., Pope, R. M., Strieter, R. M. (1995) Growth-related gene product alpha: A chemolactic cytokine for neutrophils in rheumatoid arthritis. J. Immunol. 155, 3660-3666.
18. Baynes, J. W., Thorpe, S. R., Murtiashaw, M. H. (1984) Nonenzymatic glycosylation of lysine residues in albumin. Methods Enzymol. 106, 88-98.
19. Gilcrease, M. Z., Hoover, R. L. (1990) Activated human monocytes exhibit receptor-mediated adhesion to a non-enzymatically glycosylated protein substrate. Diabetologia 33, 329-333.
20. Wolff, S. P., Jiang, Z. Y., Hunt, J. V. (1991) Protein glycation and oxidative stress in diabetes mellitus and aging. Free. Rad. Biol. Med. 10, 339-352.
21. Evanoff, H. L, Burdick M. D., Moore, S. A., Kunkel, S. L., Stricter, R. M. (1992) A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-I). Immunol. Invest. 21, 39-45.
22. Matsushima, K., Oppenheim, J. J. (1989) Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1, 2-13.
23. Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., Leonard, E. J. (1989) Human monocyte chemoattractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene. FEBS Lett. 244, 487-493.
24. Shacter, E., Arzadon, G. K., Williams, J. A. (1993) Stimulation of interleukin-6 and prostaglandin E2 secretion from peritoneal macrophages by polymers of albumin. Blood 82, 2853-2864.
25. Negoro, H., Morley, J. E., Rosenthal, M. J. (1988) Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects. Am. J. Med. 85, 360-364.
26. Peters, T., Jr. (1985) Serum albumin. Adv. Protein Chem. 37, 161-245.
27. Engerman, R., Bloodworth, J. M., Jr., Nelson, S. (1977) Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26, 760-769.
28. Karam, J. H., Forsham, P. H. (1994) Pancreatic hormone and diabetes mellitus. In Basic and Clinical Endocrinology (F. S. Greenspan and J. D. Baxter, eds.), Norwalk, CT, Appleton & Lange, 571-634.
29. Armbruster, D. A. (1987) Fructosamine: structure, analysis, and clinical usefulness. Clin. Chem. 33, 2153-2163.
30. Furth, A. J. (1988) Methods for assaying nonenzymatic glycosylation. Anal. Biochem. 175, 347-360.
31. Higgins, P. J., Bunn, H. F. (1981) Kinetic analysis of the nonenzymatic glycosylation of haemoglobin. J. Biol. Chem. 256, 5204-5208.
32. Winterhalter, K. H. (1985) Nonenzymatic glycosylation of proteins. Prog. Clin. Biol. Res. 195, 109-122.
33. Iberg, N., Fluckiger, R. (1986) Nonenzymalic glycosylation of albumin in vivo: identification of multiple glycosylated sites. J. Biol. Chem. 261, 13542-13545.
34. McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., Lyons, T. J. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91, 2470-2478.
35. Brennan, M (1989) Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J. Biol. Chem. 264, 20947-20952.
36. Buckingham, B., Reiser, K. M. (1990) Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type 1 diabetes mellitus. J. Clin. Invest. 86, 1046-1054.
37. Ulbig, M., Kampik, A., Thurau, S., Landgraf, R., Land, W. (1991) Long-term follow-up of diabetic retinopalhy up to 71 months (mean 38 months) after combined renal and pancreatic transplantation. Graefes. Arch. Clin. Exp. Ophthalmol. 229, 242-245.
38. Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., Pasagian, A. (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240, 1546-1548.
39. Miyata, T., Inagi, R., Wada, Y., Ueda, Y., Iida, Y., Takahashi, M., Taniguchi, N., Maeda, K. (1994) Glycation of human β2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. Biochemistry 33, 12215-12221.
40. Kirstein, M., Brett, J., Radoff, S., Ogawa, S., Stern, D., Vlassara, H. (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA 87, 9010-9014.
41. Kirstein, M., Aston, C., Hintz, R., Vlassara, H. (1992) Receptor-specific induction of insulin-like growth factor 1 in human monocytes by advanced glycosylation end product-modified proteins. J. Clin. Invest. 90, 439-446.
42. Schmidt, A. M., Yan, S. D., Brett, J., Mora, R., Nowygrod, R., Sterm, D. (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J. Clin. Invest. 91, 2155-2168.
43. Imani, F., Horii, Y., Suthanthiran, M., Skolnik, E. Y., Makita, Z., Sharma, V., Sehajpal, P., Vlassara, H. (1993) Advanced glycosylation end product-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling. J. Exp. Med. 178, 2165-2172.
44. Miki, S., Kasayama, S., Yoshitsugu, M., Nakamura, Y., Yamamoto, M., Sato, B., Kishimoto, T. (1993) Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro. Biochem. Biophys. Res. Commun. 196, 984-989.
45. Gilcrease, M. Z., Hoover, R. L. (1992) Secretion of a chemotactic substance(s) by AGE-stimulated human monocytes. Diabetes. Res. Clin. Pract. 16, 7-11.
46. Jaffe, G. J., Richmond, A., Le, L. V., Shattuck, R. L., Cheng, Q. C., Wong, F., Roberts, W. (1993) Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 34, 2776-2785.
47. Bian, Z. M., Elner, S. G., DelMonte, M., Stricter, R. M., Elner, V. M., (1994) Effects of glucose and insulin on human RPE secretion of interleukin-8. Invest. Ophthalmol. Vis. Sci. 3, 1884. (Abstract)
48. Morohoshi, M., Fujisawa, K., Uchimura, I., Numano, F. (1995) The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. NY Acad. Sci. 748, 562-570.
49. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., Stricter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
50. Bill, A., Romquisl, P., Alm, A. (1980) Permeability of the intraocular blood vessels. Trans Ophthalmol. Soc. UK 100, 332-336.
51. Frank, R. N. (1984) On the pathogenesis of diabetic retinopathy. Ophthalmol. 91, 626-634.
52. Cunha-Vaz, J. G. (1976) The blood-retinal barriers. Documenta Ophthalmol. 41, 287-327.
53. Miller, H., Miller, B., Ryan, S. J. (1986) The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest. Ophthalmol. Vis. Sci. 27, 1644-1652.
54. Hayreh, S. S., Servais, G. E., Virdi, P. S. (1986) Fundus lesions in malignant hypertension. VI. Hypertensive choroidopathy. Ophthalmol. 93, 1383-1400,
55. Pollack, A., Korte, G. E., Heriot, W. J., Henkind, P. (1986) Ultrastructure of Bruch's membrane after krypton laser photocoagulation. II. Repair of Bruch's membrane and the role of macrophages. Arch. Ophthalmol. 104, 1377-1382.
56. Vinores, S. A., Gadegbeku, C., Campochiaro, P. A., Green W. R. (1989) Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J. Pathol. 134, 231-235.
57. Limb, G. A., Alam, A., Earley, O., Green, W., Chignell, A. H., Dumonde, D. C. (1994) Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr. Eye. Res. 13, 791-798.
58. Ihme, A., Tavakolian, U., Pham-Duy, T. H., Wollensak, J. (1989) Characterization of cell types in vitrectomy specimens by immunohistochemical methods. In International Symposium on Proliferative Vitreoretinopathy, Koln (K. Heimann and P. Wiedemann, eds.), Heidelberg, HVA Grafische Betriebe, 73-77.
59. Shaw, S. M., Crabbe, J. C. (1994) Non-specific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions. Biochem. J. 304, 121-129.
60. Schmidt, A. M., Hasu, M., Popov, D., Zhang, J. H., Chen, J., Yan, S. D., Brett, J., Cao, R., Kuwabara, K., Costache, G., Simionescu, N., Simionescu, M., Stem, D. (1994) Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA 91, 8807-8811.
61. Vlassara, H., Brownlee, M., Cerami, A. (1988) Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37, 456-461.
62. Kwon, O. J., Au, B. T., Collins, P. D., Adcock, I. M., Mak, J. C., Robbins, R. R., Chung, K. F., Barnes, P. J. (1994) Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am. J. Physiol. 267, L398-L405.